Evidence map›Paper›PMID 26473925›Full record

ArticleToxins2015

Using S. cerevisiae as a Model System to Investigate V. cholerae VopX-Host Cell Protein Interactions and Phenotypes.

Christopher H Seward, Alexander Manzella, Ashfaqul Alam, J Scott Butler, Michelle Dziejman

Abstract read
In one paragraph

Article in Toxins, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. VopX, a novelmBio · 2025
    Article
  2. Review
  3. Vibrio variations on a type three theme.Current opinion in microbiology · 2019
    Review
  4. VopE, aFrontiers in cellular and infection microbiology · 2017
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christopher H SewardCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. seward2@illinois.edu.
Alexander ManzellaDepartment of Microbiology and Immunology, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA. amanzel2@gmail.com.
Ashfaqul AlamDepartment of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. mohammad.a.alam@emory.edu.
J Scott ButlerDepartment of Microbiology and Immunology, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA. Scott_Butler@urmc.rochester.edu.
Michelle DziejmanDepartment of Microbiology and Immunology, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA. michelle_dziejman@urmc.rochester.edu.

Funding

Pathogenic mechanisms of non-01/non-0139 V. choleraeR01AI073785 · NIAID · UNIVERSITY OF ROCHESTER · PI DZIEJMAN, MICHELLE · 2008 to 2012
$1.9M
Novel whole cell HTS for inhibitors of bacterial toxin-antitoxin interactionR01GM099731 · NIGMS · UNIVERSITY OF ROCHESTER · PI BUTLER, JAMES SCOTT · 2012 to 2014
$856k
NIAID NIH HHS AI 073785NIAID NIH HHS R01 AI073785NIGMS NIH HHS GM 09973NIGMS NIH HHS R01 GM099731
6 · The paper itself

Abstract

Most pathogenic, non-O1/non-O139 serogroup Vibrio cholerae strains cause diarrheal disease in the absence of cholera toxin. Instead, many use Type 3 Secretion System (T3SS) mediated mechanisms to disrupt host cell homeostasis. We identified a T3SS effector protein, VopX, which is translocated into mammalian cells during in vitro co-culture. In a S. cerevisiae model system, we found that expression of VopX resulted in a severe growth defect that was partially suppressed by a deletion of RLM1, encoding the terminal transcriptional regulator of the Cell Wall Integrity MAP kinase (CWI) regulated pathway. Growth of yeast cells in the presence of sorbitol also suppressed the defect, supporting a role for VopX in destabilizing the cell wall. Expression of VopX activated expression of β-galactosidase from an RLM1-reponsive element reporter fusion, but failed to do so in cells lacking MAP kinases upstream of Rlm1. The results suggest that VopX inhibits cell growth by stimulating the CWI pathway through Rlm1. Rlm1 is an ortholog of mammalian MEF2 transcription factors that are proposed to regulate cell differentiation, proliferation, and apoptosis. The collective findings suggest that VopX contributes to disease by activating MAP kinase cascades that elicit changes in cellular transcriptional programs.

Indexed as

Mitogen-Activated Protein KinasesCell CycleCell WallGene DeletionMADS Domain ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsType III Secretion SystemsVibrio choleraeVirulence FactorsMADS Domain ProteinsMitogen-Activated Protein KinasesRLM1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsType III Secretion SystemsVirulence FactorscholeraS. cerevisiae CWI pathwayType 3 Secretion SystemVopX

Identifiers

PMID26473925
PMCPMC4626723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.